502
Articles
9.9K
Citations
4
avg. Impact Factor
47
h-index

Most Cited Articles of Division of Oncology/Unit of Urology in 2020

TitleJournalYearCitations
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019European Urology2020155
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder CancerEuropean Urology202066
Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 StudyEuropean Urology202048
Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate Cancer Guidelines Panel RecommendationsEuropean Urology Focus202044
Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 TrialEuropean Urology202038
The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical ProstatectomyEuropean Urology202038
Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature ReviewEuropean Urology Oncology202037
is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signalingProceedings of the National Academy of Sciences of the United States of America202024
Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: a propensity score-matched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative GroupBJU International202023
Orsi Consensus Meeting on European Robotic Training (OCERT): Results from the First Multispecialty Consensus Meeting on Training in Robot-assisted SurgeryEuropean Urology202017
Training in robot-assisted surgeryCurrent Opinion in Urology202017
Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomySurgical Oncology202016
Robot-assisted radical prostatectomy vs. open radical prostatectomy: latest evidences on perioperative, functional and oncological outcomesCurrent Opinion in Urology202016
Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer PatientsEuropean Urology Oncology202012
Diagnostic Value of F-fluorodeoxyglucose Positron Emission Tomography with Computed Tomography for Lymph Node Staging in Patients with Upper Tract Urothelial CarcinomaEuropean Urology Oncology202012
The Use of Multiparametric Magnetic Resonance Imaging for Follow-up of Patients Included in Active Surveillance Protocol. Can PSA Density Discriminate Patients at Different Risk of Reclassification?Clinical Genitourinary Cancer202010
Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node-positive penile squamous cell carcinomaBJU International202010
Erectile Recovery After Radical Pelvic Surgery: Methodological Challenges and Recommendations for Data ReportingJournal of Sexual Medicine202010
Nephroureterectomy with or without Bladder Cuff Excision for Localized Urothelial Carcinoma of the Renal PelvisEuropean Urology Focus202010
Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 StudyEuropean Urology Oncology20209
Cytoreductive Nephrectomy in Metastatic Patients with Signs or Symptoms: Implications for Renal Cell Carcinoma GuidelinesEuropean Urology20209
A risk calculator predicting recurrence in lymph node metastatic penile cancerBJU International20209
Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted BiopsyEuropean Urology Oncology20209
The Role of Percentage of Prostate-specific Antigen Reduction After Focal Therapy Using High-intensity Focused Ultrasound for Primary Localised Prostate Cancer. Results from a Large Multi-institutional SeriesEuropean Urology20208
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US studyCancer Medicine20208